glp-1 receptor agonist use and risk of suicide death Frontiers GLP-1 receptor agonists are increasingly

Reported complications described in some GLP-1 drug claims have included: Severe or persistent gastrointestinal symptoms , such as ongoing nausea, vomiting, or abdominal pain Delayed stomach emptying (gastroparesis) , which has been described by some individuals as involving bloating, nausea, vomiting, or difficulty tolerating food Intestinal complications , including reduced bowel activity (ileus), which may involve abdominal discomfort, cramping, or vomiting Gallbladder-related conditions , such as gallstones or gallbladder inflammation Blood-clot-related conditions , including deep vein thrombosis or pulmonary embolism, described in some reports and legal filings Vision-related problems , including reports involving non-arteritic anterior ischemic optic neuropathy (NAION) discussed in connection with semaglutide in certain contexts Not everyone who takes a GLP-1 medication experiences these issues, and the relationship between GLP-1 drugs and reported complications continues to be evaluated in legal proceedings

The mechanisms that protect dermal papilla cells and extend anagen phase apply regardless of the hormonal drivers behind hair loss

doi: 10.1038/s41590-021-00996-0 98 WangYTianQHaoYYaoWLuJChenCet al

Priestley JR, Kautenburg KE, Casati MC, Endres BT, Geurts AM, Lombard JH

Injections can be weekly while refills are made on follow-ups.

2025 Jun